These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29197731)

  • 1. Synthesis and antiproliferative activity of pyrrolo[2,3-b]pyridine derivatives bearing the 1,8-naphthyridin-2-one moiety.
    Tang Q; Duan Y; Wang L; Wang M; Ouyang Y; Wang C; Mei H; Tang S; Xiong Y; Zheng P; Gong P; Zhu W
    Eur J Med Chem; 2018 Jan; 143():266-275. PubMed ID: 29197731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel 2-substituted-4-phenoxypyridine derivatives as potential antitumor agents.
    Duan Y; Xu S; Xiong H; Wang L; Zhao B; Wang P; Wang C; Peng Y; Cai S; Luo R; Zheng P; Tang Q
    Bioorg Med Chem Lett; 2018 Feb; 28(3):254-259. PubMed ID: 29317165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel pyrrolo-pyridine/pyrimidine derivatives bearing pyridazinone moiety as c-Met kinase inhibitors.
    Wang LX; Liu X; Xu S; Tang Q; Duan Y; Xiao Z; Zhi J; Jiang L; Zheng P; Zhu W
    Eur J Med Chem; 2017 Dec; 141():538-551. PubMed ID: 29107421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and bioevaluation and doking study of 1H-pyrrolo[2,3-b]pyridine derivatives bearing aromatic hydrazone moiety as c-Met inhibitors.
    Wang W; Xu S; Duan Y; Liu X; Li X; Wang C; Zhao B; Zheng P; Zhu W
    Eur J Med Chem; 2018 Feb; 145():315-327. PubMed ID: 29331754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel pyrrolo[2,3-b]pyridine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors.
    Tang Q; Wang L; Tu Y; Zhu W; Luo R; Tu Q; Wang P; Wu C; Gong P; Zheng P
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1680-4. PubMed ID: 26923692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 1,8-naphthyridin-2-one moiety.
    Tang Q; Duan Y; Xiong H; Chen T; Xiao Z; Wang L; Xiao Y; Huang S; Xiong Y; Zhu W; Gong P; Zheng P
    Eur J Med Chem; 2018 Oct; 158():201-213. PubMed ID: 30216852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
    Zhu W; Wang W; Xu S; Wang J; Tang Q; Wu C; Zhao Y; Zheng P
    Bioorg Med Chem; 2016 Apr; 24(8):1749-56. PubMed ID: 26964675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel pyrrolo[2,3-b]pyridine derivatives bearing 4-oxoquinoline moiety as potential antitumor inhibitor.
    Liu H; Duan Y; Xiong H; Zhang J; Huang S; Chen T; Zheng P; Tang Q
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126848. PubMed ID: 31836443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 2-oxo-4-chloro-1,2-dihydroquinoline-3-carboxamide moiety.
    Tang Q; Zhai X; Tu Y; Wang P; Wang L; Wu C; Wang W; Xie H; Gong P; Zheng P
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1794-8. PubMed ID: 26944614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
    Zhu W; Wang W; Xu S; Tang Q; Luo R; Wang M; Gong P; Zheng P
    Bioorg Med Chem; 2016 Feb; 24(4):812-9. PubMed ID: 26810712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents.
    Ullah S; El-Gamal MI; El-Gamal R; Pelletier J; Sévigny J; Shehata MK; Anbar HS; Iqbal J
    Eur J Med Chem; 2021 May; 217():113339. PubMed ID: 33744686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, biological evaluation and molecular modeling of novel 1H-pyrrolo[2,3-b]pyridine derivatives as potential anti-tumor agents.
    Wang R; Chen Y; Yang B; Yu S; Zhao X; Zhang C; Hao C; Zhao D; Cheng M
    Bioorg Chem; 2020 Jan; 94():103474. PubMed ID: 31859010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SYNTHESIS AND BIOLOGICAL ACTIVITY OF NOVEL 6-PHENYL-1H-PYRROLO[3,4-c]PYRIDINE-1,3-DIONE DERIVATIVES.
    Wojcicka A; Becan L; Junka A; Brtoszewicz M; Secewicz A; Trynda J; Wietrzyk J
    Acta Pol Pharm; 2017 Mar; 74(2):435-443. PubMed ID: 29624249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of pyrrolo[2,3-b]pyridine analogues as antiproliferative agents and their interaction with calf thymus DNA.
    Narva S; Chitti S; Bala BR; Alvala M; Jain N; Kondapalli VG
    Eur J Med Chem; 2016 May; 114():220-31. PubMed ID: 26994690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiproliferative activity of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives: Part II.
    Shanab K; Schirmer E; Wulz E; Weissenbacher B; Lassnig S; Slanz R; Fösleitner G; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
    Bioorg Med Chem Lett; 2011 May; 21(10):3117-21. PubMed ID: 21458262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of novel pyrrolo[2,3-b]pyridine derivatives targeting
    Abdel-Maksoud MS; Ali EMH; Ammar UM; Mersal KI; Yoo KH; Oh CH
    Bioorg Med Chem; 2020 Jun; 28(11):115493. PubMed ID: 32340792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and structure-activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents.
    Tang Q; Zhao Y; Du X; Chong L; Gong P; Guo C
    Eur J Med Chem; 2013 Nov; 69():77-89. PubMed ID: 24012712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines.
    El-Gamal MI; Jung MH; Lee WS; Sim T; Yoo KH; Oh CH
    Eur J Med Chem; 2011 Aug; 46(8):3218-26. PubMed ID: 21592628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.
    Martín-Encinas E; Rubiales G; Knudssen BR; Palacios F; Alonso C
    Eur J Med Chem; 2019 Sep; 178():752-766. PubMed ID: 31229877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of 7H-pyrrolo[2,3-d]pyrimidine derivatives containing 1,8-naphthyridine-4-one fragment.
    Zhang J; Chen P; Duan Y; Xiong H; Li H; Zeng Y; Liang G; Tang Q; Wu D
    Eur J Med Chem; 2021 Apr; 215():113273. PubMed ID: 33601310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.